Publications list for Dr Catherine Mason

2013 | 2012 | 2011 | 2010


  • Cass-Verco, J., Mason, C., Wilcken, N. (2013), Antidepressants and tamoxifen: interaction concerns. Australasian Psychiatry. , 508-509. [Abstract]
  • Ussher, J., Perz, J., Gilbert, E., Wong, W., Mason, C., Hobbs, K., Kirsten, L. (2013), Talking about sex after cancer: A discourse analytic study of health care professional accounts of sexual communication with patients. Psychology & Health. 28(12), 1370-1390. [Abstract]
  • Gilbert, E., Ussher, J., Perz, J., Wong, W., Hobbs, K., Mason, C. (2013), Men's experiences of sexuality after cancer: a material discursive intra-psychic approach. Culture, Health & Sexuality. 15(8), 881-895. [Abstract]


  • Harnett, P., Kerridge, I., Jordens, C., Hobbs, K., Mason, C., Morrell, B. (2012), Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer. Medical Journal of Australia. 196(7), 440-441. [Abstract]
  • Morrell, B., Jordens, C., Kerridge, I., Harnett, P., Hobbs, K., Mason, C. (2012), The perils of a vanishing cohort: a study of social comparisons by women with advanced ovarian cancer. Psycho-Oncology. 21(4), 382-391. [Abstract]


  • Rankin, N., Barron, J., Lane, L., Mason, C., Sinclair, S., Bishop, J. (2011), Psychosocial oncology services in New South Wales. Australian Health Review. 35(2), 156-163. [Abstract]


  • Jordens, C., Morrell, B., Harnett, P., Hobbs, K., Mason, C., Kerridge, I. (2010), Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer. Social science & medicine (1982). 71(9), 1548-56. [Abstract]